Celyad’s leadership team talks to Scrip about the critical nature of the coming months for its lead cancer therapy product, and CAR-T market differentiation.
All To Play For: CAR-T Specialist Celyad’s Big Year
By Michael Tattory|
2019-05-10T12:00:53-04:00
May 10th, 2019|News|Comments Off on All To Play For: CAR-T Specialist Celyad’s Big Year